GT Biopharma, Inc.
BiotechnologyBiopharmaceuticals/Immunotherapy
San Francisco, CA
About
GT Biopharma, Inc. is a clinical stage biopharmaceutical company dedicated to the advancement of immunotherapy treatments for cancer and other serious diseases. By focusing on the limitations of existing treatments, GT Biopharma aims to provide innovative solutions that are both targeted and effective.
Company Values
GT Biopharma distinguishes itself through its proprietary TriKE platform, which enhances the cancer-fighting abilities of a patient's own natural killer (NK) cells, offering a potentially more effective treatment modality compared to traditional therapies.